Abstract Malignant pleural mesothelioma (MPM) has a very poor prognosis. Although clinical stage is currently the only reliable prognostic factor, histologic subtyping reportedly also affects prognosis. Some studies propose reclassification of pleomorphic epithelioid as biphasic or sarcomatoid MPM. This study assessed prognostic significance and interobserver agreement in MPM subtyping of small biopsy specimens. We analyzed biopsy specimens, and clinical and survival data from records of 108 patients who were diagnosed between 2000 and 2010 at the Institute of Pathology University of Zagreb School of Medicine, of whom 98 had epithelioid MPM, six biphasic MPM, and four sarcomatoid MPM. Among epithelioid subtypes, 44 (44.9 %) were solid, 19 (19.4 %) tubulopapillary, 18 (18.4 %) acinar, six (6.1 %) adenomatoid, five (5.1 %) pleomorphic, four (4.1 %) trabecular, and two (2.0 %) micropapillary subtype. Interobserver reliability for histological diagnosis was found to be κ=0.72 (P<0.001). Median overall survival for epithelioid MPM was 10.5 months with an interquartile range (IQR) of 5.8-28.0 months but significantly shorter for the pleomorphic subtype (3 [IQR 3.0-8.0] months; P=0.034), but not significantly different from biphasic (6.5 .3] months) and sarcomatoid mesothelioma (4.0 [IQR 1.3-6.8] months; P = 0.270). We found strong reproducibility of MPM subtyping with good interobserver agreement. Furthermore, our results indicate that pleomorphic subtype to be a predictor of poor prognosis and support classifying it with sarcomatoid or biphasic MPM, as patients with the pleomorphic, biphasic, or sarcomatoid subtype show similarly poor overall survival.
Introduction
Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer that develops from mesothelial cells. MPM is most commonly caused by exposure to asbestos fibers; because of its long latency period, its increasing incidence is expected to peak in this decade, at least for developed countries [1] . Although MPM is the most common primary pleural malignancy, it is rather difficult to diagnose [2] . It is still incurable, with median survival after symptom onset of up to 12 months, despite advances in multimodality protocols [3] [4] [5] . A small number of patients have reportedly survived longer than 5 years [6, 7] . Management of patients with MPM should be based on prognostic factors with more aggressive therapy, for example, applied to patients who are expected to survive longer. Histology and TNM staging show the highest prognostic significance, although these classifications are rather robust and not precise [8] .
The current 2004 World Health Organization classification of pleural tumors [9] recognizes three main histological types of mesothelioma, epithelioid (accounting for 50-60 %), biphasic (25-35 %) , and sarcomatoid (10-20 %) [10] ; however, even within single histological types, MPM is very heterogeneous with various histological patterns, especially in the epithelioid type. The importance of histological subtyping lies in their significant bearing on survival, with epithelioid having the best prognosis [11] , whereas the pleomorphic subtype and sarcomatoid MPMs both reportedly have similarly poor outcomes [12] . The 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group recommended that MPM diagnoses include subtype if possible, with histological pattern in the description [13] . So far, only Kadota et al. have comprehensively subtyped epithelioid mesothelioma and correlated its clinicopathological characteristics and prognosis, mainly using extrapleural pneumectomy and pleurectomy decortication samples; their study suggested reclassifying pleomorphic epithelioid mesothelioma as a biphasic or sarcomatoid type based on its very poor survival [11] , which accords with an earlier study by Ordonez who analyzed ten pleomorphic mesotheliomas [12] .
This study assessed interobserver agreement in subtyping of MPM using small biopsy specimens and prognostic significance of subtypes.
Materials and methods
We identified 135 patients who were diagnosed with MPM between 2000 and 2010 at the Institute of Pathology University of Zagreb School of Medicine, using the Institute's records and specimen archives, and extracted each patient's age, sex, asbestos exposure, laterality, presence of pleural effusion, diagnostic procedure, TNM stage, and treatment from the database of the Clinic for Lung Diseases Jordanovac, University Hospital Centre Zagreb, and from the Croatian National Cancer Registry. Patients were restaged according to the seventh AJCC, using mainly computed tomography and, more recently, positron emission tomography. We ascertained patients' survival data as of 23 August 2013. This study was approved by our institutional review board.
Pathologic diagnosis was based on hematoxylin-eosin (HE)-stained slides and immunohistochemistry, using at least two positive markers of calretinin, CK 5/6, WT-1, and thrombomodulin and at least two negative markers for adenocarcinoma (carcinoembryonic antigen, thyroid transcription factor-1, and CD15).
All HE-stained slides were reviewed independently by two pathologists (L.B. and S.S.) and classified as epithelioid, sarcomatoid, or biphasic type, according to the 2004 WHO classification criteria for pleural tumors [9] , and used a median of three slides per case (range, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Epithelioid MPM were further subtyped according to their predominant patterns as acinar, adenomatoid (microglandular), micropapillary, solid, tubulopapillary, and trabecular as defined previously [11, 13, 14] (Figs. 1 and 2 ). Slides were reviewed individually by each pathologist but were reviewed together to reach a consensus in cases of disagreement. Myxoid changes in stroma were evaluated in all samples and regarded as positive if they occupied more than 50 % of a tumor sample [15] .
Statistical analysis
For all patients, potential prognostic factors were measured at the time of diagnosis and evaluated as categorical variables. Differences in survival time between histology groups were assessed with Kruskal-Wallis test with corresponding MannWhitney U test for post hoc analyses. For OS analysis, Kaplan-Meier curves were compared using log-rank test. All patients still alive at the last follow-up were censored. The Cox proportional hazards regression model was used for multivariate analysis. We calculated hazard ratios and 95 % confidence intervals. We analyzed interobserver reliability using the κ statistic to determine consistency between pathologists. P<0.05 was considered significant. All analyses used IBM SPSS Statistics 21.0 (www.spss.com; SPSS Inc., USA).
Results
Patients' demographic and clinicopathological data are summarized in Table 1 (Fig. 3) . Interobserver reliability for the two pathologists was found to be κ=0.72 (P<0.001).
Median overall survival (OS) for epithelioid type was Cox's proportional hazards regression models proved pleomorphic subtype to be a significant predictor for shorter OS (Table 2) . Compared with the pleomorphic subtype, decreased risk of death by subtype was adenomatoid; 81.5 %; tubulopapillary, 80.3 %; acinar, 73.2 %; solid, 72.9 %; trabecular, 61.5 %; and micropapillary, 58.9 %. Bivariate and multivariate analyses showed age, sex, pleural effusion, laterality, surgery type, myxoid stroma, and asbestos exposure had no prognostic significance. Moreover, the log-rank test showed that OS among patients with the pleomorphic subtype did not significantly differ from those with biphasic or sarcomatoid subtypes (P=0.270; Fig. 4 ).
Discussion
We reviewed MPM specimens from the archives of the Institute of Pathology, University of Zagreb School of Medicine, to evaluate interobserver agreement in subtyping small biopsy samples, and to evaluate the prognostic significance of subtyping.
Older-age, higher clinical stage and non-epithelioid histological types have been associated with shorter survival (review by Pass [16] ). The 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group guidelines recognized difficulties with pattern recognition in small biopsies and recommended using three main histological types (epithelioid, sarcomatoid, biphasic) with pattern descriptions in medical records, if possible [13] . Histological subtyping/patterns in many carcinomas correlate with patients' clinicopathological characteristics [17] [18] [19] [20] [21] [22] . A reclassification proposal for resectioned lung adenocarcinoma specimens has even proposed reporting different patterns by 5 % increments, based on predominant histology, as these patterns closely correlate to molecular and genetic characteristics and, more importantly, prognosis [23] .
The idea of similar correlation in MPM patients is very appealing, especially for centers that do not routinely perform extrapleural pneumonectomies and pleurectomy decortications, and relevant specimens are not abundant. Histopathological typing for MPM is apparently influenced by the size of tissue sample [24] , and those from complete surgical resection may differ from initial diagnostic biopsies [25] .
For the purpose of our study, we used tubulopapillary, adenomatoid (also called microglandular), solid, acinar, micropapillary, trabecular, and pleomorphic subtypes (the latter as defined in the 2004 WHO guidelines) [9] . We found that micropapillary, trabecular, and pleomorphic subtypes are relatively few, accounting for only 2 %, 4.1 %, and 5.1 % of MPMs, respectively. This scarcity demonstrates a limitation of our study: the small subject groups for some subtypes. It may also reflect a problem with smaller specimens. Most our samples were obtained using VATS and open biopsy, with a median of three slides reviewed per case (range, 1-16). In contrast, almost 90 % of samples in the study by Kadota K. et al. [11] were diagnosed on much larger extrapleural pneumonectomy and pleurectomy decortication specimens, resulting in significantly more reviewed slides per patient (median, 9 slides; range, 1-43). The very small size of the most of our samples occasionally made subtyping difficult, although interobserver reliability showed substantial agreement. Because of these small numbers for specific subtypes, some of our statistical results should be viewed cautiously. With that caveat, our results indicate that the very poor OS for the pleomorphic subtype of epithelioid MPM is statistically indistinguishable from biphasic and sarcomatoid types of MPM. The sarcomatoid type has the worst prognosis and is a negative predictive factor for chemotherapy and radiotherapy. To our knowledge, only one large study, by Kadota et al. [11] , has demonstrated that subtypes within the epithelioid classification had significant prognostic importance; the Kadota study suggested that the pleomorphic subtype be reclassified as biphasic or sarcomatoid, based on their similarly poor outcomes. Ordonez also showed pleomorphic epithelioid MPM to be an adverse prognostic factor in a ten-patient series [12] . Another study, by Galateau-Salle et al., reported shorter median survival of pleomorphic MPM (7 months) compared with non-pleomorphic MPM (14 months) [26] . However, some authors found no clinical variations among different histological patterns [14] .
Our OS hazard ratios should be interpreted only to indicate that the pleomorphic subtype is a negative predictor, whereas the other values indicate tendencies only for each group; for more definitive results, much larger groups of each subtype are needed. Our results might differ from those of Kadota et al. [11] for this reason, especially for the micropapillary group which only included two patients in our population.
Our findings demonstrate that histological subtyping can be performed even in small samples without abundant tumor tissue, with strong interobserver agreement, and clear prognostic implications. We strongly feel that subtypes such as acinar or adenomatoid should be retained, as we need much more data on each pattern to see their real prognostic significance, which could be obscured by fewer groupings. Although our findings should be interpreted with caution because of the few subjects with certain MPM subtypes, we do support the line that the Fig. 3 Distribution of different histological subtypes of malignant pleural mesothelioma in our study group 4 Overall survival comparison between epithelioid, pleomorphic, biphasic and sarcomatoid MPM using KaplanMeier method showed that the latter three types did not significant differ in overall survival, but they each significantly differed from that of the epithelioid type
